These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5806381)

  • 1. [On the renal excretion of Methyprylon (Noludar) and its metabolites in humans].
    Bösche J; Riebel F; Schmidt G
    Arch Toxikol; 1969; 25(1):65-75. PubMed ID: 5806381
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection, assay and rate of excretion of mecloqualone in animals and man.
    Dubnk B; Towne CA; Bush MT
    Toxicol Appl Pharmacol; 1969 Nov; 15(3):632-41. PubMed ID: 5353825
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodilaysis for methyprylon (Noludar) poisoning.
    Yudis M; Swartz C; Onesti G; Ramirez O; Snyder D; Brest A
    Ann Intern Med; 1968 Jun; 68(6):1301-4. PubMed ID: 5653624
    [No Abstract]   [Full Text] [Related]  

  • 4. [Explanation of Noludar cases in the harbor district of Hamburg (St. Pauli) by means of combined analysis methods. Preparative thin-layer chromatography, IR and mass-spectrography].
    Arnold W; Grützmacher HF
    Dtsch Z Gesamte Gerichtl Med; 1969; 65(1):44-60. PubMed ID: 5781522
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of flurazepam and its major biotransformation products in blood and urine by spectrophotofluorometry and spectrophotometry.
    de Silva JA; Strojny N
    J Pharm Sci; 1971 Sep; 60(9):1303-14. PubMed ID: 5567575
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening, identification and determination of the two new hypnotics zolpidem and zopiclone.
    Ahrens B; Schütz H; Seno H; Weiler G
    Arzneimittelforschung; 1994 Jul; 44(7):799-802. PubMed ID: 7945511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood level, excretion, and metabolite pattern of [14C]-brotizolam in humans.
    Bechtel WD; van Wayjen RG; van den Ende A
    Arzneimittelforschung; 1986 Mar; 36(3A):575-8. PubMed ID: 3718580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of renal insufficiency on the excretion of diverse drugs (chloroquine, sedatives, methacycline)].
    Fabre J; Rudhardt M; Duckert A; de Freudenreich J; Pitton JS
    Helv Med Acta Suppl; 1966 May; 46():132-3. PubMed ID: 5286254
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection and identification of nitrazepam and related compounds by thin-layer chromatography.
    Sawada H; Shinohara K
    Arch Toxikol; 1970; 27(1):71-8. PubMed ID: 5525041
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evaluation of methyprylon (noludar) as a preanaesthetic sedative hypnotic.
    DOBKIN AB; WYANT GM
    Can Anaesth Soc J; 1957 Jan; 4(1):27-36. PubMed ID: 13396638
    [No Abstract]   [Full Text] [Related]  

  • 11. [Detection and determination of bromine-containing drugs in blood, urine and tissue].
    Hauck G
    Arch Toxikol; 1968; 23(4):273-82. PubMed ID: 4387068
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatal poisoning with methyprylon (Noludar), a nonbarbiturate sedative.
    Reidt WU
    N Engl J Med; 1956 Aug; 255(5):231-2. PubMed ID: 13348845
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of metabolites of azaperone in horse urine.
    Sams RA; Gerken DF; Detra RL; Stanley SD; Wood WE; Tobin T; Yang JM; Tai HH; Jegananthan A; Watt DS
    J Pharm Sci; 1996 Jan; 85(1):79-84. PubMed ID: 8926589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Various possibilities of error in the analysis of somnifacients based on their UV spectrum].
    Post D; Schütz H
    Beitr Gerichtl Med; 1969; 25():310-9. PubMed ID: 5821389
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic fate of 2-methyl-3-o-tolyl-4(3H)-quinazolinone. 3. Metabolism of 2-methyl-3-o-tolyl-4(3H)-quinazolinone-N-oxide in vivo and in vitro.
    Murata T; Yamamoto I
    Chem Pharm Bull (Tokyo); 1970 Jan; 18(1):143-6. PubMed ID: 5417222
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study on metabolism of alpha, alpha-diethyl-3,4-methylenedioxyphenylacetamide (Hoe 264) in guinea pigs].
    Volz M
    Arzneimittelforschung; 1973 Aug; 23(8):1024-7. PubMed ID: 4801019
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical toxicity of methyprylon (noludar); case report and review of twenty-three cases.
    PELLEGRINO ED; HENDERSON RR
    J Med Soc N J; 1957 Nov; 54(11):515-8. PubMed ID: 13481568
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative studies on glutethimide (Doriden) and methyprylon (Noludar) dependency].
    Battegay R; Ladewig D
    Praxis; 1967 Nov; 56(47):1605-11. PubMed ID: 5632033
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of methyprylon (noludar) and phenobarbital on the electrocardiogram.
    SCHAFFER AI; SEEGERS W
    J Am Geriatr Soc; 1956 Nov; 4(11):1078-9. PubMed ID: 13376291
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thin layer standard chromatograms of hypnotics and meprobmate after passage through the body].
    Riechert M
    Med Lab (Stuttg); 1970 Nov; 23(11):257-64. PubMed ID: 5496701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.